Background: Entrustable professional activities (EPAs) are well-defined, executable, observable, and measurable activities that are performed by a trainee and can be performed independently as training progresses. The purpose of this study is to develop EPAs specific for the practice of apheresis medicine (AM). Methods: Members of the American Society for Apheresis Graduate Medical Education subcommittee developed a list of 28 apheresis medical activities linked to Accreditation Council for Graduate Medical Education milestones and competencies in five areas: (a) consultation, (b) clinical care for therapeutic apheresis, (c) clinical care for donor collections, (d) test optimization, and (e) vascular access. Ten AM experts using a validated tool to measure the quality of the EPAs (QUEPA) evaluated these activities with use of a Likert scale. Per group consensus, an activity was considered acceptable for each domain if it had received an average score greater than 3.7, and it was rated 4 or 5 (agree or strongly agree) by at least 70% of experts. Results: Of the 28 activities, 11 did not have acceptable QUEPA scores: 7 activities were rated as unobservable, 4 were rated unfocused, 2 were rated unrealistic and not generalizable, and 2 were rated as not addressing multiple competencies. Four activities had unacceptable scores in more than one domain. Subcommittee members edited these 11 activities over two review cycles to produce a final list of 26 activities. Conclusion: A set of practical, focused, and observable EPAs in AM were systematically developed. These EPAs can be used to assess and support trainee performance in AM.
Bibliographical noteFunding Information:
The following reviewers scored the EPAs: Andy Johnson (University of Minnesota, Pathology), Marisa Marques (University of Alabama, Pathology), Parvez Lokhandwala (Johns Hopkins, Pathology), Yara Park (University of North Carolina, Pathology), Jeffrey Winters (Mayo Clinic, Pathology), Leon Su (University of Chicago, Pathology), Ellen Klapper (Cedars-Sinai, Pathology), Nancy M. Dunbar (Dartmouth, Pathology), Srivath Poyyapakkam (University of Texas, Nephrology), Michael Linenberger (Fred Hutch, Hematology), Theresa Nester (BloodworksNW, Pathology).
© 2020 AABB